Literature DB >> 2096404

Cocaine-base smoking in rhesus monkeys: reinforcing and physiological effects.

M E Carroll1, K L Krattiger, D Gieske, D A Sadoff.   

Abstract

Four rhesus monkeys were trained to smoke cocaine-base under a progressive ratio (PR) schedule, with ten smoking trials available each day. Unit dose was varied from 0.25 to 3 mg/kg, and lidocaine (2 mg/kg) was substituted for cocaine. Number of responses and break-point on the PR schedule increased with dose while the number of smoke deliveries increased only slightly. Maximum daily smoke deliveries ranged from six to nine across monkeys. When lidocaine (2 mg/kg) was substituted for cocaine-base, responding decreased to approximately half of that maintained by cocaine, and when cocaine was reinstated, higher response rates returned. Cardiovascular changes associated with cocaine smoking were monitored with an indwelling radio transmitter. There was an initial decrease in heart rate (30 s) followed by a rapid rise and decline by the end of the 15-min trials. Blood pressure increased rapidly after trial onset and returned to pretrial baseline by 15 min. Over the eight trials completed during a session, heart rate and blood pressure steadily increased over presession base-lines during the first four trials, but there was then a decline suggesting acute tolerance development. Observations of the monkeys after each trial revealed dilated pupils and slightly agitated, hyperactive behavior. These findings indicated that smoked cocaine-base was rapidly established as a reinforcer for monkeys, and the physiological effects were similar to those reported in studies of human subjects.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2096404     DOI: 10.1007/bf02247123

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  19 in total

1.  Progressive ratio and fixed ratio schedules of cocaine-maintained responding in baboons.

Authors:  R R Griffiths; L D Bradford; J V Brady
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

Review 2.  Behavioral pharmacology of cocaine.

Authors:  M W Fischman
Journal:  J Clin Psychiatry       Date:  1988-02       Impact factor: 4.384

3.  Drinking device for rhesus monkeys.

Authors:  J E Henningfield; R A Meisch
Journal:  Pharmacol Biochem Behav       Date:  1976-05       Impact factor: 3.533

4.  A comparison of the subjective and cardiovascular effects of cocaine and lidocaine in humans.

Authors:  M W Fischman; C R Schuster; Y Hatano
Journal:  Pharmacol Biochem Behav       Date:  1983-01       Impact factor: 3.533

Review 5.  The behavioral pharmacology of alcohol and other drugs. Emerging issues.

Authors:  M E Carroll; M L Stitzer; E Strain; R A Meisch
Journal:  Recent Dev Alcohol       Date:  1990

6.  Cocaine self-administration in monkeys by chewing and smoking.

Authors:  R K Siegel; C A Johnson; J M Brewster; M E Jarvik
Journal:  Pharmacol Biochem Behav       Date:  1976-04       Impact factor: 3.533

7.  A method for delivery of precise doses of smoked cocaine-base to humans.

Authors:  D Hatsukami; R Keenan; M Carroll; E Colon; D Geiske; B Wilson; M Huber
Journal:  Pharmacol Biochem Behav       Date:  1990-05       Impact factor: 3.533

8.  Free-base cocaine smoking.

Authors:  M Perez-Reyes; S Di Guiseppi; G Ondrusek; A R Jeffcoat; C E Cook
Journal:  Clin Pharmacol Ther       Date:  1982-10       Impact factor: 6.875

9.  Cocaine-induced cocaine craving.

Authors:  J H Jaffe; N G Cascella; K M Kumor; M A Sherer
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

10.  Plasma cocaine concentrations during cocaine paste smoking.

Authors:  D Paly; P Jatlow; C Van Dyke; F R Jeri; R Byck
Journal:  Life Sci       Date:  1982-03-01       Impact factor: 5.037

View more
  13 in total

1.  Amelioration of the cardiovascular effects of cocaine in rhesus monkeys by a long-acting mutant form of cocaine esterase.

Authors:  Gregory T Collins; Kathy A Carey; Diwahar Narasimhan; Joseph Nichols; Aaron A Berlin; Nicholas W Lukacs; Roger K Sunahara; James H Woods; Mei-Chuan Ko
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

Review 2.  The behavioral pharmacology of hallucinogens.

Authors:  William E Fantegrossi; Kevin S Murnane; Chad J Reissig
Journal:  Biochem Pharmacol       Date:  2007-07-20       Impact factor: 5.858

3.  Oral caffeine pretreatment produced modest increases in smoked cocaine self-administration in rhesus monkeys.

Authors:  S D Comer; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1996-08       Impact factor: 4.530

4.  Reinforcing effects of smoked methamphetamine in rhesus monkeys.

Authors:  Jennifer L Newman; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

5.  Effects of food deprivation on cocaine base smoking in rhesus monkeys.

Authors:  S D Comer; D M Turner; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

6.  Self-administration of methamphetamine aerosol by male and female baboons.

Authors:  Richard W Foltin
Journal:  Pharmacol Biochem Behav       Date:  2018-03-13       Impact factor: 3.533

7.  Smoked heroin self-administration in rhesus monkeys.

Authors:  A J Mattox; M E Carroll
Journal:  Psychopharmacology (Berl)       Date:  1996-06       Impact factor: 4.530

8.  Social stimuli enhance phencyclidine (PCP) self-administration in rhesus monkeys.

Authors:  Jennifer L Newman; Jennifer L Perry; Marilyn E Carroll
Journal:  Pharmacol Biochem Behav       Date:  2007-05-13       Impact factor: 3.533

9.  The role of nicotine in smoking: a dual-reinforcement model.

Authors:  Anthony R Caggiula; Eric C Donny; Matthew I Palmatier; Xiu Liu; Nadia Chaudhri; Alan F Sved
Journal:  Nebr Symp Motiv       Date:  2009

Review 10.  Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity?

Authors:  William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2006-03-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.